# KALA BIO, Inc.: Form 8-K, filed Nov 10, 2025

- Company: [KALA BIO, Inc.](/companies/kala.md) (CIK 1479419)
- Form: 8-K
- Filed: 2025-11-10
- Accepted by EDGAR: Nov 10, 2025, 08:00 ET
- Period: 2025-11-09
- Accession: 0001104659-25-108844
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479419/000110465925108844/kala-20251109x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479419/000110465925108844/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479419/000110465925108844/kala-20251109x8k.htm

Filed Nov 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-108844. Last ingested by Listed: Nov 9, 2026, 18:14 ET. No prices; not investment advice.